Overview
- 24 inspections across 22 sites are on record.
- 42 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-03-28.
At a glance
Inspections
24
Sites
22
Observations
42
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Patheon Puerto Rico Inc. | 28 Mar 2013 | Human Drugs | View 483 → |
| Galephar Pharmaceutical Research Inc | 29 Sep 2011 | View 483 → | |
| McNeil Healthcare LLC. | 2 Nov 2010 | View 483 → | |
| Maribel Rodriguez-Torres, M.D. | 13 May 2010 | View 483 → | |
| Pfizer Canada ULC | 18 Mar 2010 |
Sites inspected
Patheon Puerto Rico Inc.Caguas, United States1 insp.
Galephar Pharmaceutical Research IncJuncos, United States1 insp.
McNeil Healthcare LLC.Las Piedras, United States1 insp.
Maribel Rodriguez-Torres, M.D.Santurce, United States1 insp.
Pfizer Canada ULCBrandon, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Jose R Lopez1 shared
Milva E Melendez1 shared
Ivis L Negron Torres1 shared
Marilyn Santiago1 shared
Wanda J Torres1 shared
Brenda Rivera1 shared
Full investigator report
Get the verbatim findings behind Rebecca Parrilla's 42 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site